RICE HALL JAMES & ASSOCIATES, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001230765

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q1 2024 · 257 positions · Total reported value $1.75B · Top-10 concentration 27.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 77.5% · 9 new · 172 cut · 12 exited

Active Share (vs S&P 500): 98.5% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.7% · vs SPY -6.9% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.1% · vs SPY +3.0% · Latest Value $1.89B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2024 13F filing, RICE HALL JAMES & ASSOCIATES, LLC disclosed 257 equity positions with a combined reported value of $1.75B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 27.7% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q1 2024 were LRN ($58.37M), DFIN ($56.88M), DOOR ($51.86M). By sector, the heaviest allocations are Health Care 27.0%, Consumer Discretionary 25.7%. Versus the prior quarter, allocation shifted toward Health Care (+2.9pp), Consumer Discretionary (+1.5pp) and away from Financials (-0.6pp), Other (-3.5pp).

Versus the prior quarter, RICE HALL JAMES & ASSOCIATES, LLC opened 9 new positions, trimmed 172 and fully exited 12, a turnover rate of 77.5% of positions. The portfolio's overlap with the prior quarter was 88% of names.

The largest new positions opened in Q1 2024 were ADMA ($7.96M), YOU ($6.32M), BLBD ($4.15M).

Of the 12 positions fully exited versus the prior quarter, the largest were PGTI ($25.37M), KRTX ($15.88M), CHUY ($6.67M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • ADMA ADMA BIOLOGICS INC · $7.96M
  • YOU CLEAR SECURE INC · $6.32M
  • BLBD BLUE BIRD CORP · $4.15M
  • FVRR FIVERR INTL LTD · $3.87M
  • DORM DORMAN PRODS INC · $3.83M
  • DOX AMDOCS LTD · $3.66M
  • BV BRIGHTVIEW HLDGS INC · $2.24M
  • MAMA MAMAS CREATIONS INC · $2.12M

Fully Exited (vs previous quarter)

  • PGTI PGT INNOVATIONS INC · prev qtr: $25.37M
  • KRTX KARUNA THERAPEUTICS INC · prev qtr: $15.88M
  • CHUY CHUYS HLDGS INC · prev qtr: $6.67M
  • BBBY NEIGHBORHOOD INTELLIGENCE IN · prev qtr: $5.67M
  • POWI POWER INTEGRATIONS INC · prev qtr: $4.08M
  • COLB COLUMBIA BKG SYS INC · prev qtr: $4.02M
  • HAYN HAYNES INTL INC · prev qtr: $3.74M
  • PZZA PAPA JOHNS INTL INC · prev qtr: $2.58M

Insider Transactions (Form 4)

Latest RICE HALL JAMES & ASSOCIATES, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rice Hall James & Associates, based in San Diego, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 240 positions worth $2.05B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN DIEGO, CA, United States
  • SEC registration: 801-61905 (status: Approved), registered 2003-02-13
  • Regulatory AUM (Form ADV): $1.74B as of 2026-05-06
  • Client mix (by RAUM): pension and profit-sharing plans 62%, individual investors 30%
  • Website: ricehalljames.com

Portfolio Structure

  • 240 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 24.1% of reported value
  • Largest position: LGND (LIGAND PHARMACEUTICALS INC) at 4.2%
  • Average position size: $8.56M

Sector Tilt

  • Health Care 31.6%
  • Consumer Discretionary 25.0%
  • Information Technology 20.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 12 new, 94 added, 97 reduced, 15 exited
  • 37 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 27.0%
Technology 12.6%
Financials 6.8%
Other 15.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 925.78K $58.37M 3.33%
3.33%
Reduce
2 917.21K $56.88M 3.25%
3.25%
Reduce
3 394.50K $51.86M 2.96%
2.96%
Reduce
4 4.06M $51.37M 2.93%
2.93%
Add
5 121.89K $49.26M 2.81%
2.81%
Reduce
6 1.41M $46.67M 2.67%
2.67%
Reduce
7 630.08K $45.72M 2.61%
2.61%
Reduce
8 885.81K $44.76M 2.56%
2.56%
Add
9 379.83K $41.75M 2.38%
2.38%
Reduce
10 438.69K $37.91M 2.16%
2.16%
Reduce
11 738.02K $37.57M 2.15%
2.15%
Reduce
12 290.41K $35.44M 2.02%
2.02%
Reduce
13 159.87K $31.47M 1.80%
1.80%
Reduce
14 1.04M $30.49M 1.74%
1.74%
Add
15 229.70K $28.53M 1.63%
1.63%
Reduce
16 413.05K $26.04M 1.49%
1.49%
Reduce
17 1.71M $25.40M 1.45%
1.45%
Reduce
18 162.41K $24.55M 1.40%
1.40%
Reduce
19 388.26K $20.98M 1.20%
1.20%
Reduce
20 774.44K $20.84M 1.19%
1.19%
Add
21 279.78K $20.45M 1.17%
1.17%
Add
22 515.45K $20.24M 1.16%
1.16%
Reduce
23 389.52K $18.58M 1.06%
1.06%
Reduce
24 516.77K $17.63M 1.01%
1.01%
Reduce
25 126.42K $17.44M 0.99%
0.99%
Reduce
26 903.23K $16.91M 0.96%
0.96%
Reduce
27 41.31K $16.67M 0.95%
0.95%
Reduce
28 189.66K $15.91M 0.91%
0.91%
Reduce
29 345.43K $15.70M 0.90%
0.90%
Reduce
30 340.58K $15.60M 0.89%
0.89%
Reduce
31 232.70K $15.44M 0.88%
0.88%
Hold
32 66.42K $14.80M 0.84%
0.84%
Reduce
33 193.10K $14.71M 0.84%
0.84%
Reduce
34 104.64K $14.39M 0.82%
0.82%
Reduce
35 2.64M $14.31M 0.82%
0.82%
Reduce
36 109.74K $13.50M 0.77%
0.77%
Reduce
37 71.12K $13.44M 0.77%
0.77%
Add
38 802.43K $12.72M 0.73%
0.73%
Reduce
39 880.74K $12.33M 0.70%
0.70%
Reduce
40 664.56K $12.29M 0.70%
0.70%
Reduce
41 618.80K $12.21M 0.70%
0.70%
Reduce
42 1.03M $12.12M 0.69%
0.69%
Reduce
43 2.16M $11.82M 0.68%
0.68%
Add
44 410.45K $11.48M 0.66%
0.66%
Add
45 2.15M $10.93M 0.62%
0.62%
Reduce
46 72.75K $10.88M 0.62%
0.62%
Add
47 675.76K $10.87M 0.62%
0.62%
Add
48 400.81K $10.85M 0.62%
0.62%
Add
49 367.96K $10.67M 0.61%
0.61%
Reduce
50 581.22K $10.23M 0.58%
0.58%
Hold

FAQ

What did RICE HALL JAMES & ASSOCIATES, LLC buy in 2024-Q1?

In its 2024-Q1 13F filing, RICE HALL JAMES & ASSOCIATES, LLC reported 257 equity positions worth $1.75B in aggregate; its largest disclosed positions were LRN ($58.37M), DFIN ($56.88M), DOOR ($51.86M).

How large is RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

RICE HALL JAMES & ASSOCIATES, LLC reported $1.75B of long equity holdings across 257 positions as of 2024-Q1. Top-10 holdings account for 27.7% of reported value.

What is RICE HALL JAMES & ASSOCIATES, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rice-hall-james-and-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →